Hainan Huluwa Pharmaceutical Group Bronchitis Inhaler Gets NMPA's Approval for Clinical Trials
Hainan Huluwa Pharmaceutical Group Bronchitis Inhaler Gets NMPA's Approval for Clinical Trials
葫芦娃药品集团支气管炎雾化治疗剂获得国家药品监督管理局批准进行临床试验。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册